Status | Study |
Completed |
Study Name: Prednisolone +/- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic Anemia Condition: Anemia, Hemolytic, Autoimmune Date: 2010-05-28 Interventions: Drug: prednisolone + mabthera |
Completed |
Study Name: The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders Condition: Pemphigus Auto-immune Thrombocytopenic Purpura Date: 2009-07-16 Interventions: Drug: Rituximab (MABTHERA® or RITUXAN®). patients can be included in the study whatever the do |
Completed |
Study Name: Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT) Condition: Chronic Lymphocytic Leukemia Date: 2006-03-29 Interventions: Biological: rituximab Drug: cyclophosphami |
Completed |
Study Name: Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease Condition: Anemia, Hemolytic, Autoimmune Felty Syndrome Purpura, Thro Date: 2001-02-02 Interventions: Drug: cyclophosphamide Drug: filgrastim |
Completed |
Study Name: Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases Condition: Purpura, Schoenlein-Henoch Graft Versus Host Disease Anemi Date: 2000-07-05 Interventions: Drug: anti-thymocyte globulin Drug: cyclop |
Completed |
Study Name: Treatment of Autoimmune Thrombocytopenia (AITP) Condition: Autoimmune Disease Autoimmune Hemolytic Anemia Date: 1999-11-03 Interventions: Device: Isolex 300i |